Chronic Maternal Hypertension Increases Risk for Pediatric Morbidity, Obesity
Offspring of women with chronic hypertension were twice as likely to be hospitalized for an endocrine-related issue by the age of 18.
Offspring of women with chronic hypertension were twice as likely to be hospitalized for an endocrine-related issue by the age of 18.
Nearly 1 in 3 young non-Hispanic Black adults and about 1 in 5 young Mexican-American and non-Hispanic White adults have hypertension.
The American Heart Association outlined several considerations for the management of pregnant women with CVD or CVD-related conditions.
The USPSF recommends screening all adults for hypertension with office-based blood pressure measurement.
A total of 10,527 deaths resulting from exposure to heat-related conditions were identified during 2004 to 2018.
Even in very frail people, antihypertensive treatment reduces the risk for death.
The presence of obesity, type 2 diabetes, and elevated systolic blood pressure (SBP) in adolescence accelerates the progression of risk factors that play a role in the development of early vascular aging.
The most common comorbidities among patients hospitalized with COVID-19 in the New York City area are hypertension, obesity, and diabetes.
Treatment of patients with hypertension who are infected with the severe acute respiratory syndrome coronavirus 2 with angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers may improve clinical outcomes.
Patients with cardiovascular disease diagnosed with novel coronavirus (COVID-19) are urged to continue taking their angiotensin-converting enzyme inhibitor (ACEi) and angiotensin receptor blocker (ARB) medications as prescribed.